StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PHYTO.BO$27.75+0.00%
Fair $27.75+0.0%

PHYTO.BO

Phyto Chem (India) Limited

Basic Materials / Agricultural InputsBSE

$27.75

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $27.75Fund rank 30/100 · Data gapFallback financials|
SA 19/F
F-Score: 7/9
High DebtDeclining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $17.7M · quality 52.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 71/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

19/100

F

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 3unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Debt-to-Equity ratio is 2.47, above the 2.0 threshold Revenue has declined for 2 consecutive years ROE is -15.5%, below the 5% threshold
Thesis & Journal · PHYTO.BOLocal privado en este navegador · Phyto Chem (India) Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$119M

P/E

N/A

•

EV/EBITDA

25.6x

↑

ROE

-15.5%

↓

Gross Margin

17.7%

↓

Debt/Equity

2.47

↑
52-Week Range$28
$19$35

TradingView lightweight chart

PHYTO.BO price, volumen y niveles de valoración

Último $27.75Periodo +2422.7%
Fair value: $27.75

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-15.2%

FCF CAGR

-18.8%

FCF margin

12.6%

FCF / Net income

-1.78x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $140.8M · net income $-9.9M · FCF $17.7M

2022-FY → 2025-FY

Gross margin

17.7%-16.5% pts

Operating margin

-10.3%-16.1% pts

Net margin

-7.0%-8.0% pts

FCF margin

12.6%-1.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$140.8M$140.8M$148.1M$267.6M$231.2M
Net Income$-9.9M$-9.9M$-33.3M$2.2M$2.3M
EBITDA$10.8M$10.8M$-10.2M$27.5M$26.9M
EPS-2.31-2.31-7.750.520.53
Gross Margin17.7%17.7%12.2%33.0%34.2%
Operating Margin-10.3%-10.3%-24.0%9.2%5.7%
Net Margin-7.0%-7.0%-22.5%0.8%1.0%
Balance Sheet
Debt/Equity2.472.472.471.832.03
Cash Flow
Free Cash Flow$17.7M$17.7M$30.7M$14.2M$33.0M
Returns
ROE-15.5%-15.5%-45.3%2.1%2.2%
Valuation
P/E———73.0441.13
EV/EBITDA25.5525.55—12.9911.32
P/B1.871.872.121.540.90
Growth & Yield
Revenue Growth-4.9%-4.9%-44.7%15.7%—
EPS Growth70.2%70.2%-1590.4%-1.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.7%

Total return

-8.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-7.75 → -2.31

Residual

-8.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-8.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.